These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3583489)

  • 21. Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
    Lorian V; Pavletich K
    Drugs Exp Clin Res; 1994; 20(5):209-14. PubMed ID: 7875058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xibornol: multiple dose pharmacokinetics and diffusion in lung, tonsillar tissue and laryngeal mucosa.
    Scaglione F; Trazzi R; Odero A; Sambataro G; Savio G; Ferrara F; Fraschini F
    Int J Clin Pharmacol Res; 1988; 8(6):457-61. PubMed ID: 3253223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penetration of roxithromycin in bronchial secretions.
    De Rose V; Ferrara A; Mangiarotti P; Nonis A; Bertoletti R; Gialdroni Grassi G
    Int J Clin Pharmacol Res; 1988; 8(2):107-10. PubMed ID: 3378852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue penetration and metabolism of ciprofloxacin.
    Wise R; Donovan IA
    Am J Med; 1987 Apr; 82(4A):103-7. PubMed ID: 3578319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical and pharmacokinetic study of ciprofloxacin at the level of the respiratory system].
    De Rose V; Mangiarotti P; Ferrara AM; Bertoletti R; Grassi G; Manara G; Grassi C
    G Ital Chemioter; 1987; 34(1-3):57-61. PubMed ID: 3504415
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bacteriological findings in bronchial secretions of children with chronic, nontuberculous lung diseases and their relationship to local transferrin values].
    Groh A; Gruhn I; Kittlick M; Stelzner A
    Z Erkr Atmungsorgane; 1988; 171(3):224-9. PubMed ID: 3222973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple-dose pharmacokinetics in serum and sputum of sagamicin administered intramuscularly to patients.
    Fraschini F; Scaglione F; Scarpazza G; Marchi M; Braga PC
    Chemotherapy; 1987; 33(2):85-92. PubMed ID: 3568801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of dose size on bioavailability of ciprofloxacin.
    Plaisance KI; Drusano GL; Forrest A; Bustamante CI; Standiford HC
    Antimicrob Agents Chemother; 1987 Jun; 31(6):956-8. PubMed ID: 3619432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of ciprofloxacin in peripheral lymph and skin blisters.
    Bergan T; Engeset A; Olszewski W; Ostby N; Solberg R
    Eur J Clin Microbiol; 1986 Aug; 5(4):458-61. PubMed ID: 3758057
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacokinetics of single dose intravenous ciprofloxacin in patients undergoing gastrointestinal surgery.
    Silverman SH; Johnson M; Burdon DW; Keighley MR
    J Antimicrob Chemother; 1986 Jul; 18(1):107-12. PubMed ID: 2944864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The successive cultivation of sputum in nonspecific pulmonary diseases and the accordance of the results (author's transl)].
    Kozamernik-Stojković M; Gashi A
    Plucne Bolesti Tuberk; 1978; 30(3):254-7. PubMed ID: 733969
    [No Abstract]   [Full Text] [Related]  

  • 32. Concentration and distribution of soluble and insoluble macromolecules from sputum: a possible estimation of the hydration of sputum macromolecules.
    Lhermitte M; Lafitte JJ; Perini JM; Galabert C; Filliat M; Lamblin G; Roussel P
    Lung; 1986; 164(4):217-31. PubMed ID: 3091966
    [No Abstract]   [Full Text] [Related]  

  • 33. On the origin of yeasts in sputum.
    Fragner P; Bohut V; Mĕricka O; Stupecký J
    Rev Czech Med; 1977; 23(1):28-36. PubMed ID: 403582
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro characterization of ciprofloxacin distribution in rat lung.
    Reinoso RF; Navarro AS; Lanao JM
    Methods Find Exp Clin Pharmacol; 1998 Jun; 20(5):369-75. PubMed ID: 9701774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penetration of ciprofloxacin into human lung tissue following intravenous injection.
    Schlenkhoff D; Dalhoff A; Knopf J; Opferkuch W
    Infection; 1986; 14(6):299-300. PubMed ID: 3818107
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessment of soluble parameters in sputum.
    Stockley RA; Lomas D
    Agents Actions Suppl; 1990; 30():145-60. PubMed ID: 2239526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal elimination of sulfo-ciprofloxacin, a new metabolite of ciprofloxacin.
    Borner K; Lode H; Höffken G
    Eur J Clin Microbiol; 1986 Aug; 5(4):476. PubMed ID: 3758059
    [No Abstract]   [Full Text] [Related]  

  • 38. Ciprofloxacin: drug metabolism and pharmacokinetic profile.
    Al-Omar MA
    Profiles Drug Subst Excip Relat Methodol; 2005; 31():209-14. PubMed ID: 22469042
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials.
    Aminimanizani A; Beringer P; Jelliffe R
    Clin Pharmacokinet; 2001; 40(3):169-87. PubMed ID: 11327197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penetration of ciprofloxacin into bronchial secretions from mechanically ventilated patients with nosocomial bronchopneumonia.
    Saux P; Martin C; Mallet MN; Papazian L; Bruguerolle B; De Micco P; Gouin F
    Antimicrob Agents Chemother; 1994 Apr; 38(4):901-4. PubMed ID: 8031070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.